Home

JEFFREY B KINDLER

CIK 1174454 · Executive Chairman · last filed 2026-08-28

JEFFREY B KINDLER is an Executive Chairman who has filed 180 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing shows the insider sold $1.4M of PGEN on Aug 28, 2026. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.0M across reported positions. 39 SEC filings were submitted jointly with INTREXON CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$25.02M

Companies

10

Total Filings

180

Lifetime Open-Market Net

-$2.46M

Filer Profile

Reported Address
C/O PERRIGO COMPANY PLC
515 EASTERN AVENUE
ALLEGAN, MI 49010
Related Filers
INTREXON CORP — 39 joint filings, latest 2026-08-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PGEN Director 17,100 $6.85 $117.1K -$3.09M 18 2026-08-28
PRAX Director 2,537 $334.58 $848.8K $0 2 2026-06-12
Terns Pharmaceuticals, Inc. (TERN) Delisted Director — $52.95 — $0 9 2026-05-05
PRGO Director 10,559 $13.66 $144.2K -$497.5K 15 2025-05-16
PPD, Inc. (PPD) Delisted Director 0 $47.28 $0 $499.5K 4 2021-12-08
VTVT Executive Chairman 875 $31.97 $28.0K $0 7 2020-06-15
SIGA Director 127,339 $3.03 $385.8K $0 10 2020-05-22
PRECIGEN, INC. (XON) Delisted Director 84,040 — — $627.7K 16 2019-03-26
CMG Director 15,650 $36.20 $566.5K $0 2 2013-05-17
PFE Former Chairman & CEO 827,296 $27.72 $22.93M $0 91 2010-12-17

Recent Filings

180 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-28 PGEN Sell (S) −185,000 -$1.38M EDGAR
2026-08-26 PGEN Notice (144) −185,000 -$1.37M EDGAR
2026-06-12 PRAX Grant (A) +1,371 $0 EDGAR
2026-05-28 PRGO Notice (144) −14,357 -$164.2K EDGAR
2026-05-05 Terns Pharmaceuticals, Inc. (TERN) Delisted Disp (D) — $0 EDGAR
2026-03-16 PGEN Exer (M) +71,839 $0 EDGAR
2026-03-12 PGEN Grant (A) +19,658 $69.0K EDGAR
2026-02-10 PRAX Grant (A) +1,166 $0 EDGAR
2026-02-02 Terns Pharmaceuticals, Inc. (TERN) Delisted Grant (A) — $0 EDGAR
2025-12-16 PGEN Sell (S) −235,467 -$855.9K EDGAR
Showing 1–10 of 180
Page 1 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.